Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Multivariate Prediction Equations for HbA<sub>1c</sub> Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic ModelingMichael Willis, Christian Asseburg, Andreas Nilsson, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 8, 2018
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United StatesCheryl Neslusan, Anna Teschemaker, Michael Willis, et al.Journal of Comparative Effectiveness Research|September 24, 2025
The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in CanadaMichael Willis, Andreas Nilsson, Hamza Alshannaq, et al.Acta Clinica Belgica|December 27, 2021
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in BelgiumWinde Jorissen, Lieven Annemans, Nicolas Louis, et al.Journal of Health Economics and Outcomes Research|August 25, 2021
Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. SettingMichael Willis, Sandra Erntoft, Sofie Persson, et al.Plos One|October 14, 2014
Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equationsAdam Lundqvist, Katarina Steen Carlsson, Pierre Johansen, et al.Pharmacoeconomics|January 22, 2016
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes MellitusMartin Henriksson, Ramandeep Jindal, Catarina Sternhufvud, et al.Schizophrenia Research and Treatment|September 12, 2012
Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting InjectionChristian Asseburg, Michael Willis, Mickael Löthgren, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2025
Cost-effectiveness models of non-small cell lung cancer: A systematic literature reviewMichael Willis, Andreas Nilsson, Zin Min Thet Lwin, et al.Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|July 28, 2016
Cost-effectiveness of Canagliflozin versus Sitagliptin When Added to Metformin and Sulfonylurea in Type 2 Diabetes in CanadaSuthakar Sabapathy, Cheryl Neslusan, Kim Yoong, et al.Pageof 6